Understand the source comparison
KLOW Myths Cost Money Health: Peptide Supplier Comparison
'98% purity is research-grade' Impurity fraction includes bioactive fragments that compete at target receptors. CV increases 2–3× in binding assays $3,000–$5,000 per failed study from non-reproducible data and required restarts Mechanistic studies require ≥99%
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- '98% purity is research-grade'
- Impurity fraction includes bioactive fragments that compete at target receptors. CV increases 2–3× in binding assays
- $3,000–$5,000 per failed study from non-reproducible data and required restarts
- Mechanistic studies require ≥99% purity minimum. 98% material appropriate only for preliminary screening or non-receptor assays
- 'Lyophilised peptides stable at room temp indefinitely'
- Oxidation and deamidation continue in solid state. Potency loss 10–20% over 6 months at 25°C for sensitive sequences
- $800–$1,200 per compromised batch from undetected degradation leading to weak or variable activity
- Store all lyophilised peptides at −20°C immediately upon receipt. Ambient storage acceptable maximum 72 hours
- 'Any bacteriostatic water works for reconstitution'
- pH, ionic strength, and buffer composition affect peptide stability 5–10×. Degradation rates vary from 1% to 15% per week depending on medium
- $400–$900 per vial from premature degradation and dose inconsistency after week 2–3
- Match reconstitution medium to peptide sequence. Request supplier guidance or literature pH stability data before mixing
- 'Cold chain shipping unnecessary for lyophilised material'
- Temperature excursions above 25°C during transit accelerate solid-state degradation. Summer shipments show 5–8% purity loss before arrival
- $200–$500 per order from degraded starting material requiring immediate reorder
- Require cold chain shipping May–September or in warm climates. Insulated packaging alone insufficient above 30°C